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Diffuse cutaneous manifestation in a new mother with
COVID-19 (SARS-Cov-2)
Dear Editor,
In the city of Wuhan (Hubei province) in China, during the
month of December 2019, an inexplicable increase in number
of atypical pneumonia cases arose.1 The cause of these pneu-
monias has been related to a zoonotic-transmitted virus named
severe acute respiratory syndrome coronavirus 2 (SARS-Cov-
2), which leads to the resultant disease named as coronavirus
disease 2019 (COVID-19).1,2
The main initial clinical manifestations of SARS-Cov-2
infection are: fever, dry cough, rhinorrhea, fatigue, arthralgias,
myalgias, and headache. The onset of a dyspnea associated
with an underlying bilateral interstitial pneumonia is a complica-
tion of this infection, causing a respiratory failure that in some
cases requires invasive or noninvasive mechanical ventilation.
In addition, a large number of recent cases characterized by
viral-related thrombophilic vasculitis are increasingly observed.
A mild leukopenia and an elevation of lactate dehydrogenase
(LDH) can be present in COVID-19 patients.1 Finally, neurologi-
cal symptoms (such as ageusia and anosmia) also highlight a
neurological tropism of SARS-Cov-2. In most cases, the dis-
ease passes asymptomatically or with only mild symptoms with-
out requiring any hospitalization with only a period of quarantine
at home.4
As with all other viral diseases, the skin can also be
affected in COVID-19 patients. A 37-year-old Caucasian
woman, in her 7th postpartum day, developed fever (up to
39 °C), dry cough, myalgia, and arthralgia; her husband devel-
oped the same symptoms. Her personal medical history was
negative for cutaneous and internal diseases, she denied any
allergies, the childbirth had no complications, and routine labo-
ratory investigations did not show abnormalities. Five days
before the onset of these symptoms, the patient had direct con-
tact with an asymptomatic COVID-19 patient, confirmed with a
nasopharyngeal and oropharyngeal swab. There were no signs
of dyspnea, and the vital signs (including saturation) were all in
normal range. A diagnosis of COVID-19 was made. The patient
was obligated to quarantine at home and was advised to come
to the hospital only in the event of clinical worsening. A symp-
tomatic treatment with only acetaminophen was prescribed.
Breastfeeding has not been suspended.
After 3 days from the onset of the symptoms and in her
10th postpartum day, the patient developed a craniocaudal
cutaneous manifestation characterized by erythematous macu-
lopapular lesions on the trunk, neck, and face (Fig. 1a–c). Addi-
tionally, there were cutaneous lesions characterized by
nummular erythematous lesions with a peripheral slight white
halo, assuming an urticaria-like feature in the lower limbs
(Fig. 2). She denied itching. The patient emailed us a photo of
the cutaneous lesions, and a medical call was also performed.
After 8 days, the cutaneous lesions clearly improved along with
improvement of the general symptoms and absence of fever
and dry cough. The newborn did not show any symptom of the
disease and did not develop any cutaneous lesion. Her husband
also showed a clear general improvement without having devel-
oped any cutaneous lesion.
Currently, there are only two articles that described a
total of 19 cases of cutaneous manifestations in COVID-19
patients, mainly characterized by erythematous rash, wide-
spread urticaria, chickenpox-like vesicles, with a predilection
for the trunk1 and one case presenting with a skin rash with
petechiae resembling dengue.5 However, in both articles, the
authors did not report any picture of the described cutaneous
lesions.1-5 While there are two recent reports that highlight the
presence of acro-ischemia due to an existence of hypercoagu-
lation status associated with COVID-19, this was not observed
in our patient.5,6
Our case shows a cutaneous manifestation in a new
mother with COVID-19 characterized by the simultaneous pres-
ence of erythematous, maculopapular lesions and urticaria-like
skin lesions, further highlighting the variety of the clinical
(a) (b) (c)
Figure 1 (a) Erythematous maculopapular
lesions on the trunk in the absence of
itching. (b) Erythematous maculopapular
lesions on the trunk, with more erythema in
the back. (c) Involvement of the head-neck
region. The lesions showed a craniocaudal
development
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features which are associated with this new disease, still little
known. Again, our case highlights that newborns and children in
97% of cases do not develop severe respiratory symptoms,
without showing clear clinical manifestations, although they can
be an important viral reservoir.7 Women with COVID-19 can
breastfeed. Moreover, our case also highlights how telemedi-
cine plays a very important role in supporting patients confined
at home during the coronavirus pandemic emergency.
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Figure 2 Nummular erythematous lesions with a peripheral slight
white halo, assuming urticaria-like features, specifically resembling
an adrenergic urticaria
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